Nuclear Factor- κβ Expression in Invasive Breast Cancer

Document Type : Original Article

Authors

1 Department of Pathology, Faculty of Medicine, Zagazig University, Egypt

2 Professor of Pathology Department, Faculty of Medicine, Zagazig University, Egypt

3 Assistant Professor of Pathology Department, Faculty of Medicine, Zagazig University, Egypt

Abstract

Background: Find out how NF-κβ/p65 plays a role in breast cancer development. NF-κβ/p65 expression was investigated in breast cancer and its molecular subgroups to ascertain the association between NF-κβ/p65 expression and clinicopathological features. This study aimed to assess the immunohistochemistry expression of NF-κβ/p65 in invasive breast cancer was the goal of the current investigation. Both clinicopathological characteristics and immunohistochemical-based subtypes of the patients under study were evaluated in relation to the expression of NF-κβ/p65. Methods: The immunohistochemistry expression of the NF-κβ/p65 receptor was examined in 82 paraffin-embedded slices from invasive breast cancer. Results: NF-κβ/p65 expression was found to be substantially linked with tumor size, grade, pathological stage, Her2-enriched and triple negative subtypes, and Ki67 levels. Furthermore, there was a significant inverse association between the expression of NF-κβ/p65 and the progesterone receptor (PR) and oestrogen receptor (ER). There was no significant correlation between age, axillary lymph node status, distant metastases, or tumor histological subtypes and NF-κβ/p65 expression. Conclusion: Breast cancer's aggressive biological properties have been connected to the expression of NF-κβ/p65.

Keywords

Main Subjects

Zagazig University Medical Journal
Volume 31, Issue 4
April 2025
Pages 1407-1417

Files

Share

How to cite

Statistics